Pharma Marketing Business for Sale in Delhi, India
Distributors & wholesalers of critical care life-saving medicines and supplying to hospitals across the country.
This transaction has concluded.
Premium Plan
| Established | 10-20 year(s) |
| Employees | 2 - 5 |
| Legal Entity | General Partnership |
| Reported Sales | USD 460 thousand |
| Run Rate Sales | USD 730 thousand |
| EBITDA Margin | 10 - 20 % |
| Industries | Pharma Marketing |
| Locations | Delhi |
| Local Time | 4:57 AM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
Full Sale
Asking Price:
USD
50 thousand
(Native Currency: INR 4,500,000)
Reason: Business owner is relocating.
Includes physical assets worth
USD
16.7 thousand
Interested to connect with advisors
Documents
Business Overview
- Business is operating since 2011 and located in Delhi.
- Our affordable and convenient distribution services include the supply of specialty drugs including Life-Saving Blood Plasma Medicines, Oncology, Immunology, Critical Care and Vaccines.
- We are suppliers of more than 100 products to various Govt. hospitals, Corporate hospitals, Nursing Homes, Multi-Specialty Hospitals and other renowned medicines distributors across India.
- We are authorized dealers of 18 - 20 pharma products manufacturing companies in India.
- Authorized direct channel partners for renowned companies such as - Unimark Remedies, Shilpa Medicare Remedies, Hemarus Therapeutics Ltd, Reliance Life Sciences, Synergy, Cadila Pharma, Plasmagen Lifesciences, Gsk Lifesciences, Virchow Biotech, Prosper Channel, Kedrion Bio Pharma, Qualichem Biologicals, Zuventus India Ltd, Admac Lifesciences & many more.
- We are also working with companies on fast moving and high in demand items. Some of those companies are Wockhardt, Lupin Pharma, Khandelwal Labs, Baxter India, Bristol Myers Squibb, Sanofi India, Emcure, Cipla, Zydus, Intas.
- Our affordable and convenient distribution services include the supply of specialty drugs including Life-Saving Blood Plasma Medicines, Oncology, Immunology, Critical Care and Vaccines.
- We are suppliers of more than 100 products to various Govt. hospitals, Corporate hospitals, Nursing Homes, Multi-Specialty Hospitals and other renowned medicines distributors across India.
- We are authorized dealers of 18 - 20 pharma products manufacturing companies in India.
- Authorized direct channel partners for renowned companies such as - Unimark Remedies, Shilpa Medicare Remedies, Hemarus Therapeutics Ltd, Reliance Life Sciences, Synergy, Cadila Pharma, Plasmagen Lifesciences, Gsk Lifesciences, Virchow Biotech, Prosper Channel, Kedrion Bio Pharma, Qualichem Biologicals, Zuventus India Ltd, Admac Lifesciences & many more.
- We are also working with companies on fast moving and high in demand items. Some of those companies are Wockhardt, Lupin Pharma, Khandelwal Labs, Baxter India, Bristol Myers Squibb, Sanofi India, Emcure, Cipla, Zydus, Intas.
Products & Services Overview
Specialty drugs including Life-Saving Blood Plasma Medicines, Oncology, Immunology, Critical Care and Vaccines.
Facilities Overview
Rented office and a small godown with cold storage and stock maintaining space. Total area size is around 250 sqft.
Capitalization Overview
Not Disclosed
Recent Activity
-
Earlier than 15 daysBrand Marketing Manager, Oil & Gas, New Delhi, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysMD, Plastics And Chemicals, Hyderabad, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysProduction Manager, Pharmaceutical, Narsinghpur, Individual Investor / Buyer connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
